Key Meeting Information

  • The 41st Annual General Meeting is scheduled for Tuesday, August 11, 2026, at 4:00 p.m. (IST)
  • Meeting will be conducted through Video Conferencing/Other Audio-Visual Means (VC/OAVM)
  • Cut-off date for determining voting eligibility: Tuesday, August 4, 2026
  • Remote e-voting period: Friday, August 7, 2026 (9:00 A.M. IST) to Monday, August 10, 2026 (5:00 P.M. IST)
  • E-voting facility will also be available during the AGM for those who haven't voted remotely

Ordinary Business Items

Item 1: Adoption of Financial Statements

  • To consider and adopt Audited Standalone Financial Statements for FY ended March 31, 2026
  • To consider and adopt Audited Consolidated Financial Statements for FY ended March 31, 2026
  • Includes reports of Board of Directors and Auditors

Item 2: Re-appointment of Dr. Haribabu Bodepudi (DIN: 01119687)

  • Managing Director and Group CEO
  • Retires by rotation and offers himself for re-appointment
  • Liable to retire by rotation

Item 3: Re-appointment of Mr. Rajaram Narayanan (DIN: 02977405)

  • Whole-time Director and CEO - Animal Health
  • Retires by rotation and offers himself for re-appointment
  • Liable to retire by rotation

Special Business Items

Item 4: Ratification of Revised Cost Auditor Remuneration for FY 2025-26

  • M/s. Joshi Apte & Associates, Practicing Cost Accountants (Firm Registration Number: 000240)
  • Originally appointed at remuneration of ₹1,50,000 plus applicable taxes and expenses
  • Revised to ₹3,00,000 plus applicable taxes and reimbursement of out-of-pocket expenses
  • Revision due to increased scope of work post-merger with multiple entities
  • Merger sanctioned by NCLT order dated November 18, 2025, effective December 16, 2025
  • Includes Viyash Life Sciences Private Limited, Symed Labs Limited, Vandana Life Sciences Private Limited, Appcure Labs Private Limited, Vindhya Pharma (India) Private Limited, S.V. Labs Private Limited, Vindhya Organics Private Limited, Geninn Life Sciences Private Limited, Sequent Research Limited

Item 5: Ratification of Cost Auditor Remuneration for FY 2026-27

  • M/s. Joshi Apte & Associates reappointed as Cost Auditors
  • Remuneration of ₹6,00,000 plus applicable taxes and reimbursement of out-of-pocket expenses
  • Reflects expanded scope including merged entities

Item 6: Adoption of New Articles of Association

  • Comprehensive revision to align with Companies Act 2013 provisions
  • Based on Table F of Schedule I of the Act
  • Requires Special Resolution approval

Director Information

Dr. Haribabu Bodepudi

  • Date of first appointment: August 7, 2023
  • Qualification: PhD in Organic Chemistry from Andhra University
  • Experience: Over 30 years in pharmaceutical industry, former COO/CEO of Mylan India
  • Shareholding: 1,20,99,324 equity shares
  • Board meetings attended: 8 of 8
  • Tenure: December 16, 2025 to December 15, 2027

Mr. Rajaram Narayanan

  • Date of first appointment: April 11, 2022
  • Qualification: BE (Hons) Electrical & Electronics from BITS Pilani, MBA from IIFT New Delhi, Advanced Management Program from Harvard Business School
  • Experience: 25+ years, former Managing Director of Sanofi India Limited, former CMO at Airtel
  • Shareholding: 18,34,735 equity shares
  • Board meetings attended: 8 of 8
  • Tenure: Up to April 11, 2027
  • Other directorships: Alivira Animal Health Limited, Topkim Topkapi ilac Premiks Sanayi Ve Ticaret Anonik Sirketi, Provet Veterinary Ürünleri San. Ve Tic. A. Ş., Vila Viña Participacions S.L., Laboratorios Karizoo, S.A.

Voting and Participation Details

  • Remote e-voting through NSDL platform
  • Maximum 1,000 members can participate via VC/OAVM on first-come-first-served basis
  • Large shareholders (2%+ holding), promoters, institutional investors, directors, KMPs, committee chairpersons, and auditors exempt from participation limit
  • Scrutinizer: Nishant Darak & Associates, represented by Mr. Nishant Darak (Membership No. A71502, COP No. 26646)
  • Members must pre-register by August 9, 2026, to speak during the meeting

Additional Information

  • Annual Report available at company website: https://www.viyash.com/investor-relation
  • Documents available for electronic inspection from notice circulation date until AGM date
  • SEBI mandate requires all securities issuance in dematerialized form only
  • Members urged to update KYC details including PAN, contact details, bank account details, and specimen signature
  • Registrar and Transfer Agent: KFin Technologies Limited